Some 60 million people in the United States are now eligible for a Pfizer booster shot against COVID-19, President Joe Biden said on Friday as a regulatory marathon laying bare divisions within the scientific community on ...
Sep 25, 2021
0
4
Millions of Americans are now eligible to receive a Pfizer booster shot to help increase their protection against the worst effects of the coronavirus.
Sep 24, 2021
0
4
The EU's drug watchdog said Thursday it expected to decide in early October whether to approve boosters of the Pfizer/BioNTech COVID-19 vaccine for over 16s.
Sep 23, 2021
0
2
It's shaping up to be a big week for news on two eagerly awaited developments involving Pfizer's COVID-19 vaccine: Booster shots and progress toward its first doses for children as young as five.
Sep 22, 2021
0
18
Health officials in the Thai capital made headway Tuesday in their effort to vaccinate children against the coronavirus, giving shots of the Pfizer vaccine to students aged 12 to 18 with underlying diseases.
Sep 21, 2021
0
3
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon—a key step toward beginning vaccinations for youngsters.
Sep 20, 2021
0
1
Pfizer and BioNTech on Monday said trial results showed their coronavirus vaccine is safe and produces a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
Sep 20, 2021
0
1
A new study released by the US Centers for Disease Control and Prevention (CDC) on Friday is the latest to suggest the Moderna Covid vaccine confers better long-term protection against hospitalization than Pfizer.
Sep 17, 2021
0
20
(HealthDay)—Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday.
Sep 17, 2021
0
25
James Cook University scientists have developed a new model to track the COVID pandemic—and it's telling them Australia should now prioritize delivering the Pfizer vaccine to 12-40 year-olds.
Sep 6, 2021
3
17
